BEAM (carmustine (BCNU), etoposide, cytarabine, melphalan)

DRUG2 trials

Sponsors

University of Nebraska, Ruijin Hospital

Conditions

Mantle Cell LymphomaMantle Cell Lymphoma (MCL)Non-hodgkin's Lymphoma

Phase 1

VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma, or Mantle Cell Lymphoma

CompletedNCT00571493

University of NebraskaMantle Cell Lymphoma, Non-hodgkin's Lymphoma

Start: 2006-04-14End: 2014-11-01Updated: 2023-09-28

Phase 2

Orelabrutinib and Rituximab With Optional Autologous Hematopoietic Stem Cell Transplantation in MCL Treatment

RecruitingNCT07199296

Ruijin HospitalMantle Cell Lymphoma (MCL)

Start: 2025-07-01End: 2028-07-01Target: 45Updated: 2025-09-30